Carbimazole

DB00389

small molecule approved investigational

Deskripsi

An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity.

Struktur Molekul 2D

Berat 186.232
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

446 Data
Prednisone Carbimazole may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.
Prednisolone Carbimazole may increase the excretion rate of Prednisolone which could result in a lower serum level and potentially a reduction in efficacy.
Fluvoxamine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Fluvoxamine.
Citalopram The therapeutic efficacy of Carbimazole can be decreased when used in combination with Citalopram.
Fluoxetine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Fluoxetine.
Duloxetine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Duloxetine.
Trazodone The therapeutic efficacy of Carbimazole can be decreased when used in combination with Trazodone.
Paroxetine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Paroxetine.
Sertraline The therapeutic efficacy of Carbimazole can be decreased when used in combination with Sertraline.
Sibutramine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Sibutramine.
Nefazodone The therapeutic efficacy of Carbimazole can be decreased when used in combination with Nefazodone.
Escitalopram The therapeutic efficacy of Carbimazole can be decreased when used in combination with Escitalopram.
Zimelidine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Zimelidine.
Dapoxetine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Dapoxetine.
Milnacipran The therapeutic efficacy of Carbimazole can be decreased when used in combination with Milnacipran.
Desvenlafaxine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Desvenlafaxine.
Seproxetine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Seproxetine.
Indalpine The therapeutic efficacy of Carbimazole can be decreased when used in combination with Indalpine.
Ritanserin The therapeutic efficacy of Carbimazole can be decreased when used in combination with Ritanserin.
Alaproclate The therapeutic efficacy of Carbimazole can be decreased when used in combination with Alaproclate.
Digoxin The serum concentration of Digoxin can be increased when it is combined with Carbimazole.
Acetyldigitoxin The serum concentration of Acetyldigitoxin can be increased when it is combined with Carbimazole.
Deslanoside The serum concentration of Deslanoside can be increased when it is combined with Carbimazole.
Ouabain The serum concentration of Ouabain can be increased when it is combined with Carbimazole.
Digitoxin The serum concentration of Digitoxin can be increased when it is combined with Carbimazole.
Oleandrin The serum concentration of Oleandrin can be increased when it is combined with Carbimazole.
Cymarin The serum concentration of Cymarin can be increased when it is combined with Carbimazole.
Proscillaridin The serum concentration of Proscillaridin can be increased when it is combined with Carbimazole.
Metildigoxin The serum concentration of Metildigoxin can be increased when it is combined with Carbimazole.
Lanatoside C The serum concentration of Lanatoside C can be increased when it is combined with Carbimazole.
Gitoformate The serum concentration of Gitoformate can be increased when it is combined with Carbimazole.
Acetyldigoxin The serum concentration of Acetyldigoxin can be increased when it is combined with Carbimazole.
Peruvoside The serum concentration of Peruvoside can be increased when it is combined with Carbimazole.
Iodide I-131 The therapeutic efficacy of Iodide I-131 can be decreased when used in combination with Carbimazole.
Lepirudin Carbimazole may increase the anticoagulant activities of Lepirudin.
Bivalirudin Carbimazole may increase the anticoagulant activities of Bivalirudin.
Alteplase Carbimazole may increase the anticoagulant activities of Alteplase.
Urokinase Carbimazole may increase the anticoagulant activities of Urokinase.
Reteplase Carbimazole may increase the anticoagulant activities of Reteplase.
Anistreplase Carbimazole may increase the anticoagulant activities of Anistreplase.
Tenecteplase Carbimazole may increase the anticoagulant activities of Tenecteplase.
Abciximab Carbimazole may increase the anticoagulant activities of Abciximab.
Drotrecogin alfa Carbimazole may increase the anticoagulant activities of Drotrecogin alfa.
Streptokinase Carbimazole may increase the anticoagulant activities of Streptokinase.
Dicoumarol Carbimazole may increase the anticoagulant activities of Dicoumarol.
Argatroban Carbimazole may increase the anticoagulant activities of Argatroban.
Ardeparin Carbimazole may increase the anticoagulant activities of Ardeparin.
Phenindione Carbimazole may increase the anticoagulant activities of Phenindione.
Fondaparinux Carbimazole may increase the anticoagulant activities of Fondaparinux.
Warfarin Carbimazole may increase the anticoagulant activities of Warfarin.
Pentosan polysulfate Carbimazole may increase the anticoagulant activities of Pentosan polysulfate.
Phenprocoumon Carbimazole may increase the anticoagulant activities of Phenprocoumon.
Dipyridamole Carbimazole may increase the anticoagulant activities of Dipyridamole.
Heparin Carbimazole may increase the anticoagulant activities of Heparin.
Enoxaparin Carbimazole may increase the anticoagulant activities of Enoxaparin.
Epoprostenol Carbimazole may increase the anticoagulant activities of Epoprostenol.
Acenocoumarol Carbimazole may increase the anticoagulant activities of Acenocoumarol.
4-hydroxycoumarin Carbimazole may increase the anticoagulant activities of 4-hydroxycoumarin.
Coumarin Carbimazole may increase the anticoagulant activities of Coumarin.
Ximelagatran Carbimazole may increase the anticoagulant activities of Ximelagatran.
Desmoteplase Carbimazole may increase the anticoagulant activities of Desmoteplase.
Defibrotide Carbimazole may increase the anticoagulant activities of Defibrotide.
Ancrod Carbimazole may increase the anticoagulant activities of Ancrod.
Beraprost Carbimazole may increase the anticoagulant activities of Beraprost.
Prasugrel Carbimazole may increase the anticoagulant activities of Prasugrel.
Rivaroxaban Carbimazole may increase the anticoagulant activities of Rivaroxaban.
Sulodexide Carbimazole may increase the anticoagulant activities of Sulodexide.
Semuloparin Carbimazole may increase the anticoagulant activities of Semuloparin.
Idraparinux Carbimazole may increase the anticoagulant activities of Idraparinux.
Cangrelor Carbimazole may increase the anticoagulant activities of Cangrelor.
Astaxanthin Carbimazole may increase the anticoagulant activities of Astaxanthin.
Apixaban Carbimazole may increase the anticoagulant activities of Apixaban.
Otamixaban Carbimazole may increase the anticoagulant activities of Otamixaban.
Amediplase Carbimazole may increase the anticoagulant activities of Amediplase.
Dabigatran etexilate Carbimazole may increase the anticoagulant activities of Dabigatran etexilate.
Danaparoid Carbimazole may increase the anticoagulant activities of Danaparoid.
Dalteparin Carbimazole may increase the anticoagulant activities of Dalteparin.
Tinzaparin Carbimazole may increase the anticoagulant activities of Tinzaparin.
(R)-warfarin Carbimazole may increase the anticoagulant activities of (R)-warfarin.
Ethyl biscoumacetate Carbimazole may increase the anticoagulant activities of Ethyl biscoumacetate.
Nadroparin Carbimazole may increase the anticoagulant activities of Nadroparin.
Triflusal Carbimazole may increase the anticoagulant activities of Triflusal.
Ticagrelor Carbimazole may increase the anticoagulant activities of Ticagrelor.
Ditazole Carbimazole may increase the anticoagulant activities of Ditazole.
Vorapaxar Carbimazole may increase the anticoagulant activities of Vorapaxar.
Edoxaban Carbimazole may increase the anticoagulant activities of Edoxaban.
Sodium citrate Carbimazole may increase the anticoagulant activities of Sodium citrate.
Dextran Carbimazole may increase the anticoagulant activities of Dextran.
Bemiparin Carbimazole may increase the anticoagulant activities of Bemiparin.
Parnaparin Carbimazole may increase the anticoagulant activities of Parnaparin.
Desirudin Carbimazole may increase the anticoagulant activities of Desirudin.
Antithrombin Alfa Carbimazole may increase the anticoagulant activities of Antithrombin Alfa.
Protein C Carbimazole may increase the anticoagulant activities of Protein C.
Antithrombin III human Carbimazole may increase the anticoagulant activities of Antithrombin III human.
Letaxaban Carbimazole may increase the anticoagulant activities of Letaxaban.
Darexaban Carbimazole may increase the anticoagulant activities of Darexaban.
Betrixaban Carbimazole may increase the anticoagulant activities of Betrixaban.
Nafamostat Carbimazole may increase the anticoagulant activities of Nafamostat.
Monteplase Carbimazole may increase the anticoagulant activities of Monteplase.
Gabexate Carbimazole may increase the anticoagulant activities of Gabexate.

Target Protein

Thyroid peroxidase TPO

Contoh Produk & Brand

Produk: 0 • International brands: 11
International Brands
  • Camen — Dalim
  • Carbimazol — Sanofi-Aventis
  • Carbinom — XL Lab
  • Carbizol — Square
  • Neomercazole — Abbott
  • Neomerdin — MedChoice
  • Newmazole — Genuine
  • Thyrocab — Abbott
  • Thyrostat — Ni-The
  • Tyrazol — Orion

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul